Amedisys Statistics
Share Statistics
Amedisys has 32.75M shares outstanding. The number of shares has increased by 0.27% in one year.
| Shares Outstanding | 32.75M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.04% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 31.96M |
| Failed to Deliver (FTD) Shares | 1.34K |
| FTD / Avg. Volume | 0.23% |
Short Selling Information
The latest short interest is 2.21M, so 6.75% of the outstanding shares have been sold short.
| Short Interest | 2.21M |
| Short % of Shares Out | 6.75% |
| Short % of Float | 6.9% |
| Short Ratio (days to cover) | 3.97 |
Valuation Ratios
The PE ratio is -316.87 and the forward PE ratio is 17.81.
| PE Ratio | -316.87 |
| Forward PE | 17.81 |
| PS Ratio | 1.38 |
| Forward PS | 1.1 |
| PB Ratio | 2.9 |
| P/FCF Ratio | 24.81 |
| PEG Ratio | n/a |
Enterprise Valuation
Amedisys Inc. has an Enterprise Value (EV) of 3.44B.
| EV / Earnings | -352.95 |
| EV / Sales | 1.54 |
| EV / EBITDA | 15.86 |
| EV / EBIT | 22 |
| EV / FCF | 27.64 |
Financial Position
The company has a current ratio of 1.05, with a Debt / Equity ratio of 0.36.
| Current Ratio | 1.05 |
| Quick Ratio | 1.05 |
| Debt / Equity | 0.36 |
| Total Debt / Capitalization | 26.43 |
| Cash Flow / Debt | 0.36 |
| Interest Coverage | 5 |
Financial Efficiency
Return on equity (ROE) is -0.01% and return on capital (ROIC) is -2.69%.
| Return on Equity (ROE) | -0.01% |
| Return on Assets (ROA) | 0% |
| Return on Capital (ROIC) | -2.69% |
| Revenue Per Employee | 117.70K |
| Profits Per Employee | -513 |
| Employee Count | 19.00K |
| Asset Turnover | 1.09 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 50.56M |
| Effective Tax Rate | 1.28 |
Stock Price Statistics
The stock price has increased by -3.26% in the last 52 weeks. The beta is 0.78, so Amedisys 's price volatility has been higher than the market average.
| Beta | 0.78 |
| 52-Week Price Change | -3.26% |
| 50-Day Moving Average | 89.78 |
| 200-Day Moving Average | 93.97 |
| Relative Strength Index (RSI) | 67.26 |
| Average Volume (20 Days) | 583.50K |
Income Statement
In the last 12 months, Amedisys had revenue of 2.24B and earned -9.75M in profits. Earnings per share was -0.3.
| Revenue | 2.24B |
| Gross Profit | 990.87M |
| Operating Income | 156.39M |
| Net Income | -9.75M |
| EBITDA | 216.91M |
| EBIT | 156.39M |
| Earnings Per Share (EPS) | -0.3 |
Balance Sheet
The company has 126.45M in cash and 487.21M in debt, giving a net cash position of -360.76M.
| Cash & Cash Equivalents | 126.45M |
| Total Debt | 487.21M |
| Net Cash | -360.76M |
| Retained Earnings | 747.92M |
| Total Assets | 2.14B |
| Working Capital | 93.93M |
Cash Flow
In the last 12 months, operating cash flow was 137.19M and capital expenditures -12.71M, giving a free cash flow of 124.47M.
| Operating Cash Flow | 137.19M |
| Capital Expenditures | -12.71M |
| Free Cash Flow | 124.47M |
| FCF Per Share | 3.83 |
Margins
Gross margin is 44.31%, with operating and profit margins of 6.99% and -0.44%.
| Gross Margin | 44.31% |
| Operating Margin | 6.99% |
| Pretax Margin | 1.77% |
| Profit Margin | -0.44% |
| EBITDA Margin | 9.7% |
| EBIT Margin | 6.99% |
| FCF Margin | 5.57% |
Dividends & Yields
AMED does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -0.33% |
| FCF Yield | 4.13% |
Analyst Forecast
The average price target for AMED is $101, which is 9.8% higher than the current price. The consensus rating is "Hold".
| Price Target | $101 |
| Price Target Difference | 9.8% |
| Analyst Consensus | Hold |
| Analyst Count | 5 |
Stock Splits
The last stock split was on Dec 5, 2006. It was a forward split with a ratio of 4:3.
| Last Split Date | Dec 5, 2006 |
| Split Type | forward |
| Split Ratio | 4:3 |
Scores
| Altman Z-Score | 3.86 |
| Piotroski F-Score | 5 |